The Company respectfully submits that the payout value of the EARs is based on the positive excess of (i) the common stock equivalent (as defined in the EAR Plan) value (the “CSE Value”) on the date of the applicable payout event, less (ii) the Grant Date Value (as defined in the EAR Plan).
The CSE Value is defined in accordance with the EAR Plan as the highest of (1) an amount calculated by using a formula based on certain financial metrics of Acushnet Company as of and for the year ended December 31, 2015, (2) an amount calculated by using a formula based on certain financial metrics of
Rest of the answer
Acushnet Company as of and for the year ended December 31, 2016 and (3) if an IPO has occurred, an amount calculated based on the average per share closing price of the publicly traded common stock for the first full three trading days following the pricing of common stock in the IPO. The Grant Date Value is $100.00 per EAR.
Under ASC 718, the Company was required to calculate the estimated payout value of its outstanding EARs for purposes of determining the fair value of such EARs and the related liability and compensation expense. Therefore, to estimate the payout value of the EARs, the Company applied the definition of CSE Value set forth in the EAR Plan. As further explained below, the estimated payout value of each EAR calculated under clauses (1) and (2) of such definition is significantly higher than the estimated payout value calculated under clause (3) of such definition because such estimated payout value under clauses (1) and (2) is determined using a specified formula based on certain financial metrics. Because the estimated payout value was highest using clause (2) of the CSE Value definition set forth in the EAR Plan, the Company used such value for purposes of determining the fair value of such EARs and the related liability and compensation expense.
To explain in further detail, the Company respectfully submits that the estimated payout values using each clause of the CSE Value definition set forth the EAR Plan are calculated as follows:
Clause (1) — The Amount Based on 2015 Financial Metrics
The CSE Value under clause (1) is calculated in accordance with the EAR Plan using the following formula:
(i) Plan Adjusted EBITDA for 2015 of $210.4 million (which amount is disclosed on page 185 of Amendment No. 3 to the Company’s Registration Statement on Form S-1), multiplied by 10.8, minus
(ii) all outstanding indebtedness of Acushnet Company and its subsidiaries as of December 31, 2015 of $444.2 million, plus
(iii) cash and cash equivalents of the Company and its subsidiaries as of December 31, 2015 of $51.4 million and the cumulative interest, dividends and fees paid on or in respect of the Convertible Preferred Stock, the Convertible Notes and the 7.5% bonds due 2021, and any other interest, dividends, distribution or fees paid to the Company’s stockholders over the period beginning on March 31, 2011 and ending on December 31, 2015 of $200.1 million, divided by
(iv) the number of shares of the Company’s common stock outstanding on an as converted, fully diluted basis as of December 31, 2015 of 8,232,622 shares.
This formula resulted in an estimated CSE Value for each EAR of $252.83 and therefore an estimated payout value for each EAR of $152.83 (which equals the estimated CSE Value of $252.83 minus the Grant Date Value of $100.00).
Clause (2) — The Amount Based on 2016 Financial Metrics
The CSE Value under clause (2) is calculated in accordance with the EAR Plan using the following formula:
(i) Plan Adjusted EBITDA for 2016 multiplied by 10.8,
(ii) outstanding indebtedness of the Company and its subsidiaries as of December 31, 2016,
(iii) cash and cash equivalents of the Company and its subsidiaries as of December 31, 2016 and the cumulative interest, dividends and fees paid on or in respect of the Convertible Preferred Stock, the Convertible Notes and the 7.5% bonds due 2021, and any other interest, dividends, distribution or fees paid to the Company’s stockholders over the period beginning on March 31, 2011 and ending on December 31, 2016,
(iv) the number of shares of the Company’s common stock outstanding on an as converted, fully diluted basis as of December 31, 2016.
Because fiscal 2016 is not yet complete, the Company used forecasted amounts for the above financial metrics when calculating the estimated CSE Value in accordance with clause (2) for accounting purposes. Such forecasted amounts are based on the Company’s internal budget and forecast as of and for the year ended December 31, 2016 and therefore such amounts are not disclosed herein or in the Company’s Registration Statement on Form S-1.
This formula resulted in an estimated CSE Value for each EAR of $274.26 and therefore an estimated payout value for each EAR of $174.26 (which is the estimated CSE Value of $274.26 minus the Grant Date Value of $100.00).
Clause (3) — The Amount Based on Average Per Share Closing Price
Because an IPO has not yet occurred, the CSE Value calculated in accordance with the EAR Plan under clause (3) would be zero. However, under ASC 718, the Company is required to estimate the payout value under clause (3) using a fair value pricing model. Applying a Black-Scholes valuation, a standard fair value pricing model, the Company calculated the estimated payout value using the following inputs:
The Company used a stock price of $184.02, which was based on the fair value of the Company’s common stock using the most recently available third-party valuation (which is the same as the fair value used by the Company to determine the fair value of the awards approved by the Company’s board of directors on June 15, 2016, as described on page 134 of the Registration Statement on Form S-1).
The Company used an exercise price of $100.00 (which is the Grant Date Value of the EARs).
The Company used a time to maturity of 0.3 years as the anticipated IPO date at the time of calculation was approximately four months after June 30, 2016.
The Company used an annual risk-free interest rate of 0.26%, which was interpolated from the Constant Maturity Treasury Rate as of June 30, 2016 as published by the United States Department of the Treasury, with the maturity matching the anticipated IPO date.
The Company used an annualized volatility of 35%, which was based on the equity volatilities of a peer group of publicly-traded companies, based on 6-month historical weekly stock price returns for such peer group.
Using the inputs described above, the Black-Scholes calculation resulted in an estimated payout value for each EAR of $84.10.
The Company respectfully notes that the estimated CSE Values and estimated payout values discussed above were determined using the number of CSEs and Grant Date Value prior to the Company’s 9-to-1 stock split it expects to effectuate prior to the launch of its offering.
We have attached as Exhibit A to this letter a marked version of page 133 of the Registration Statement showing revisions the Company expects to include in an amendment to its Registration Statement on Form S-1 and the preliminary prospectus for the offering in response to the Staff’s comment.
Recent Developments
We have attached as Exhibit B to this letter a draft of the “Summary—Recent Developments” section that presents a range of the Company’s estimated net sales, net income (loss) attributable to Acushnet Holdings Corp. and Adjusted EBITDA (including a reconciliation of the mid-point of the estimated range for net income (loss) attributable to Acushnet Holdings Corp. to the mid-point of the estimated range for Adjusted EBITDA) for the three months ended September 30, 2016, compared to the Company’s net sales, net income (loss) attributable to Acushnet Holdings Corp. and Adjusted EBITDA for the three months ended September 30, 2015. The Company expects to provide this information to potential investors by including it in the preliminary prospectus for the offering.